Whitepaper: BioFire® mycoplasma solution: results in one hour, fully automated detection system
Posted: 25 June 2020 | bioMérieux | No comments yet
In this whitepaper, bioMérieux describe the potential application of BioFire® FilmArray technology – a well-recognised technology used in infectious disease diagnostics – for rapid at-line detection of mycoplasmas in the pharmaceutical industry.
Routine testing for microbial contaminants is critically required in biopharmaceutical manufacturing to maintain control over product quality, safety and efficacy. In this whitepaper, we describe the potential application of BioFire® FilmArray technology – a well-recognised technology used in infectious disease diagnostics – for rapid at-line detection of mycoplasmas in the pharmaceutical industry.1
Related content from this organisation
- EPR Podcast Episode 5 – ATMP manufacturing and QC – Rey Mali, Accellix and Félix Montero-Julian, bioMérieux
- Application note: A new, more flexible endotoxin test platform
- Article: Survey of the status of rFC and LAL equivalence determination
- Whitepaper: Recombinant factor C: new Ph. Eur. Chapter 2.6.32
- Application Notes & Whitepapers 2020
Issue
Related topics
Cell culture automation, Manufacturing, Rapid Microbiological Methods (RMMs), Technology
